Unlocking 5-MeO-DMT: New Paths for Mental Health

Exploring the Non-Hallucinogenic Therapeutic Potential of 5-MeO-DMT

10 mins
What is it about?

Medicine and Health

Science and Maths


Psychedelic substances like LSD and psilocybin show promise in treating neuropsychiatric disorders. These drugs typically interact with serotonin receptors, specifically 5-HT2A and 5-HT1A. This study explores how the lesser-known psychedelic, 5-MeO-DMT, interacts with these receptors to understand its potential therapeutic benefits.